Connect MDS and AML: The myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) disease registry.
David P. Steensma
Consultant or Advisory Role - Celgene
Mehrdad Abedi
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Research Funding - Celgene
Eyal C. Attar
Honoraria - Celgene
Rafael Bejar
Consultant or Advisory Role - Celgene; Genoptix
Honoraria - Celgene; Genoptix
Christopher R. Cogle
Consultant or Advisory Role - Celgene
Research Funding - Leukemia Lymphoma Society; NIH
Guillermo Garcia-Manero
No relevant relationships to disclose
David L. Grinblatt
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Xiaomei Ma
Consultant or Advisory Role - Celgene
Jaroslaw P. Maciejewski
Honoraria - Celgene; Eisai
Daniel Aaron Pollyea
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Research Funding - Celgene
Gail J. Roboz
Consultant or Advisory Role - Celgene
Michael Savona
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Incyte
Other Remuneration - Karyopharm Therapeutics
Bart L. Scott
No relevant relationships to disclose
Mikkael A. Sekeres
Consultant or Advisory Role - Celgene
Michael A. Thompson
Consultant or Advisory Role - Celgene
Oleg Zernovak
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Mary M. Sugrue
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Arlene S. Swern
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Melissa Nifenecker
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Harry Paul Erba
Honoraria - Celgene